Family Medicine Doctors in Hutto, TX Accepting Medicare
6 Family Medicine doctors found. Showing 1 - 6
 Dr. Kyle M Suire, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 151 Exchange Blvd Ste 500, Hutto, TX 78634 Phone: 512-846-1244 Fax: 512-406-7324 |
 Bethany Sheryl Beauchamp, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 4810 Gattis School Rd Ste 100, Hutto, TX 78634 Phone: 512-312-7230 |
Jackie Vance, FNP-BC Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1003 Mccormick Cv, Hutto, TX 78634 Phone: 847-525-5821 |
Christine M Eady, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 4810 Gattis School Rd Ste 100, Hutto, TX 78634 Phone: 512-312-7230 |
Heather Lenz, PA-C Family Medicine Medicare: Medicare Enrolled Practice Location: 151 Exchange Blvd, Hutto, TX 78634 Phone: 512-846-1244 Fax: 512-406-7324 |
Daniel Ortiz, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 120 Ed Schmidt Blvd Ste Be&f, Hutto, TX 78634 Phone: 512-509-9500 Fax: 512-509-9503 |
News Archive
Altered default network connectivity in FEP patients
Patients with a first episode of psychosis show altered functional connectivity in the dorsomedial prefrontal cortex default network subsystem, researchers report.
Two opposing mechanisms support voluntary forgetting of unwanted memories
If only there were a way to forget that humiliating faux pas at last night's dinner party. It turns out there's not one, but two opposite ways in which the brain allows us to voluntarily forget unwanted memories, according to a study published by Cell Press October 17 in the journal Neuron.
Trigger discovered that causes stem cells embryos to start developing into organs
They have apparently discovered the chemical trigger that causes stem cells from embryos to start developing into organs, raising the possibility of parts of the body being able to repair their own damage.
Archivel Farma to start phase II clinical trials of RUTI vaccine for Latent Tuberculosis
Archivel Farma, S.L. has announced that its breakthrough treatment for tuberculosis (TB) will shortly start phase II clinical trials. The treatment uses the company's unique combination of its novel therapeutic vaccine called RUTI® in conjunction with an antibiotic. This cuts treatment time from nine months to one month, which reduces side effects and healthcare costs, by preventing re-infection during the eradication process. The company expects commercial availability in 2015.
Abbott to commercialize Celera's CE-marked KIF6 genotyping assay outside U.S.
Celera Corporation and Abbott today announced that they have signed an exclusive distribution agreement to market Celera's CE-marked KIF6 diagnostic test for use on Abbott's CE-marked m2000™ instrument system. The KIF6 genotyping assay detects a genetic marker that may be used in conjunction with clinical evaluation and patient assessment for the identification of individuals at risk for coronary heart disease (CHD), and in patients for whom statin treatment is being considered.
› Verified 9 days ago